1. Home
  2. FLEX vs TEVA Comparison

FLEX vs TEVA Comparison

Compare FLEX & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flex Ltd.

FLEX

Flex Ltd.

HOLD

Current Price

$95.09

Market Cap

33.8B

Sector

Technology

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$35.80

Market Cap

33.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLEX
TEVA
Founded
1990
1901
Country
United States
Israel
Employees
147979
32842
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.8B
33.5B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
FLEX
TEVA
Price
$95.09
$35.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
8
Target Price
$66.89
$38.63
AVG Volume (30 Days)
3.3M
5.5M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.66
N/A
Revenue
$28,679,925,000.00
N/A
Revenue This Year
$8.14
N/A
Revenue Next Year
$6.28
$2.97
P/E Ratio
$55.34
$28.19
Revenue Growth
18.95
N/A
52 Week Low
$34.94
$14.99
52 Week High
$93.53
$37.35

Technical Indicators

Market Signals
Indicator
FLEX
TEVA
Relative Strength Index (RSI) 76.55 71.92
Support Level $60.15 $30.53
Resistance Level N/A $37.35
Average True Range (ATR) 3.14 0.96
MACD 0.45 0.49
Stochastic Oscillator 98.39 95.24

Price Performance

Historical Comparison
FLEX
TEVA

About FLEX Flex Ltd.

Flex Ltd is a contract manufacturing company providing comprehensive electronics design, manufacturing, and product management services to electronics and technology companies. The company's operating segments include Flex Agility Solutions (FAS) and Flex Reliability Solutions (FRS). Flex Agility Solutions segment includes markets such as Communications, Enterprise and Cloud; Lifestyle; and Consumer Devices. Flex Reliability Solutions segment includes markets such as Automotive, Health Solutions, and Industrial.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: